Loading
Total declarations
Companies
▲ Purchases (15 ops.)
▼ Sales (0 ops.)
Latest filing published 07 Aug 2026 for Bausch & Lomb Corp, €61k. Read the official filing
Filing timeline
BuySaleBrent l. Saunders
Insider track record
Disclosed buys
15
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
-22.7%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Brent l. Saunders: trading record in brief
Brent l. Saunders is a declared insider at 6 companies (chief executive); the most frequent names are Allergan plc, Bausch & Lomb Corp and SkinHealth Systems Inc. The record holds 56 filings, for trades running from 30 June 2016 to 5 August 2026.
No open-market sale appears; the market trades are 15 purchases worth €3.7M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 35 share grants and 3 option exercises. 2026 to date brings 1 purchase and no sales.
A typical purchase (the median) is worth €217k. Of 15 purchases, 8 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The newest entry dates from 7 August 2026: a share grant, in Bausch & Lomb Corp. The clock since the last published purchase (10 March 2026) now reads 225 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Brent l. Saunders
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
4,231 shares@ US$16.76Common Shares, No Par ValueSEC:0001860742-26-000089:0
281,879 shares0Common Shares, No Par ValueSEC:0001860742-26-000089:1
2,886 shares@ US$15.920.0007% mcap2.2% of flowCommon Shares, No Par ValueSEC:0001860742-26-000071:0
14,700 shares@ US$17.146.4% of flowCommon Shares, No Par ValueSEC:0001860742-26-000054:0
Canonical exit: 4 Jun 2026 (T+90)
22,059 shares@ US$18.4910.2% of flowCommon Shares, No Par ValueSEC:0001860742-26-000041:0
327,102 shares0Common Shares, No Par ValueSEC:0001860742-26-000028:0
65,444 shares@ US$17.9929.5% of flowCommon Shares, No Par ValueSEC:0001860742-26-000027:0
4,231 shares@ US$14.442.9% of flowCommon Shares, No Par ValueSEC:0001127602-25-020237:0
73,051 sharesClass A Common StockSEC:0001628280-25-032141:0
22,000 shares0Common Shares, No Par ValueSEC:0001127602-25-015582:1
22,000 shares@ US$11.2766.1% of flowCommon Shares, No Par ValueSEC:0001127602-25-015582:0
Canonical exit: 20 Aug 2025 (T+90)
120,000 shares@ US$1.01100.0% of flowCommon StockSEC:0001415889-25-014185:0
168,168 shares0Common Shares, No Par ValueSEC:0001127602-25-007260:0
73,782 shares@ US$17.8371.6% of flowCommon Shares, No Par ValueSEC:0001127602-24-030056:0
40,450 shares@ US$1.086.9% of flowClass A Common StockSEC:0001628280-24-036967:0
Canonical exit: 10 Nov 2024 (T+90)
32,250 shares@ US$15.66126.2% of flowCommon Shares, No Par ValueSEC:0001127602-24-021823:0
Canonical exit: 3 Nov 2024 (T+90)
3,711 shares@ US$16.889.8% of flowClass A Common StockSEC:0001628280-24-031586:0
187,919 shares0Common Shares, No Par ValueSEC:0001127602-24-007883:0
59,380 shares@ US$6.102657.6% of flowClass A Common StockSEC:0001628280-23-029854:0
Canonical exit: 14 Nov 2023 (T+90)
16,357 sharesClass A Common StockSEC:0001628280-23-022509:0
5,001 shares0Common StockSEC:0001209191-22-060763:0
35,581 sharesClass A Common StockSEC:0001818093-22-000031:0
6,812 shares@ US$12.2416.6% of flowClass A Common StockSEC:0001818093-22-000021:0
17,600 shares@ US$14.4818100.0% of flowCommon StockSEC:0000899243-22-000193:0
Canonical exit: 29 Mar 2022 (T+90)
4,180 shares0Common StockSEC:0001209191-21-069855:0
25 of 28 declarations
